ClearPoint Neuro, Inc. (CLPT)
9.14
-0.11
(-1.19%)
USD |
NASDAQ |
Oct 23, 16:00
9.20
+0.06
(+0.66%)
After-Hours: 20:00
ClearPoint Neuro Gross Profit Margin (Quarterly) : 59.79% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 59.79% |
| March 31, 2026 | 62.24% |
| December 31, 2025 | 61.52% |
| September 30, 2025 | 63.20% |
| June 30, 2025 | 60.29% |
| March 31, 2025 | 60.48% |
| December 31, 2024 | 61.28% |
| September 30, 2024 | 59.68% |
| June 30, 2024 | 63.48% |
| March 31, 2024 | 59.24% |
| December 31, 2023 | 58.93% |
| September 30, 2023 | 56.80% |
| June 30, 2023 | 52.54% |
| March 31, 2023 | 58.94% |
| December 31, 2022 | 64.09% |
| September 30, 2022 | 72.13% |
| June 30, 2022 | 62.63% |
| March 31, 2022 | 64.52% |
| December 31, 2021 | 76.81% |
| September 30, 2021 | 67.51% |
| June 30, 2021 | 67.10% |
| March 31, 2021 | 64.86% |
| December 31, 2020 | 61.46% |
| September 30, 2020 | 79.57% |
| June 30, 2020 | 74.14% |
| Date | Value |
|---|---|
| March 31, 2020 | 70.56% |
| December 31, 2019 | 70.94% |
| September 30, 2019 | 66.42% |
| June 30, 2019 | 60.47% |
| March 31, 2019 | 64.15% |
| December 31, 2018 | 69.73% |
| September 30, 2018 | 69.39% |
| June 30, 2018 | 63.42% |
| March 31, 2018 | 63.72% |
| December 31, 2017 | 60.76% |
| September 30, 2017 | 59.88% |
| June 30, 2017 | 59.59% |
| March 31, 2017 | 62.51% |
| December 31, 2016 | 58.60% |
| September 30, 2016 | 53.70% |
| June 30, 2016 | 52.80% |
| March 31, 2016 | 50.04% |
| December 31, 2015 | 57.21% |
| September 30, 2015 | 55.04% |
| June 30, 2015 | 52.19% |
| March 31, 2015 | 61.84% |
| December 31, 2014 | 28.78% |
| September 30, 2014 | 50.13% |
| June 30, 2014 | 51.48% |
| March 31, 2014 | 57.36% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| SINTX Technologies, Inc. | 61.50% |
| Abbott Laboratories | 57.05% |
| AngioDynamics, Inc. | 56.00% |
| Alphatec Holdings, Inc. | 62.90% |
| AtriCure, Inc. | 76.75% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -185.3% |
| Return on Assets | -42.75% |
| Return on Invested Capital | -49.35% |
| Profit Margin (Quarterly) | -104.2% |
| Operating Margin (Quarterly) | -94.15% |
| Return on Net Operating Assets | -85.41% |